FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073075774> ?p ?o ?g. }

• W2073075774 abstract "Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CABreast cancer is the second leading cause of cancer-related death in American women. Triple negative breast cancers (TNBCs), which lack expression of common therapeutic targets ERα and HER2, are particularly aggressive and correlated with decreased survival. While TNBCs make up 15-20% of all breast cancer cases, they account for a disproportionately large amount of breast cancer morbidity. Recently, our group has developed a novel therapeutic approach utilizing nanoparticle technology to increase targeted delivery of chemotherapeutic agents, specifically aminoflavone (AF, NSC 686288) to a model TNBC cell line that shows exquisite sensitivity to AF. We have found that AF, a synthetic flavonoid compound, exerts growth inhibitory effects in two TNBC cell lines, MDA-MB-468 and Cal51, with IC50 values in the low nanomolar range. However, in vivo studies examining the efficacy of AF indicate dose-limiting pulmonary toxicity, creating a need for drug delivery systems that circumvent toxicity through specific targeting mechanisms. This method exploits the overexpression of epidermal growth factor receptor (EGFR) commonly associated with TNBC by utilizing a unimolecular micelle nanoparticle conjugated with an EGFR-specific peptide (GE11) formed by dendritic poly(amido amine) (PAMAM) polylactide (PLA)- polyethylene glycol (PEG) amphiphilic block copolymers. The unimolecular micelle nanoparticle was also conjugated with Cy5.5 dye to allow for visualization and detection of the particles at the cellular level. Uniform size distribution and spherical morphology of the particles was confirmed using dynamic light scattering and transmission electron microscopy. Using the EGFR-overexpressing and AF-sensitive human MDA-MB-468 TNBC cell line, we were able to show that nanoparticles containing the EGFR-specific peptide GE11 exhibited increased cellular uptake, as shown using confocal microscopy for imaging and subsequent fluorescence intensity analysis. Furthermore, flow cytometric analysis confirmed that MDA-MB-468 cells treated with GE11-containing nanoparticles exhibit increased fluorescence intensity as compared to cells treated with non-targeting particles, which were not conjugated to GE11. This data suggests that the use of GE11-conjugated unimolecular micelles is an effective means of specifically targeted drug delivery in an EGFR-overexpressing TNBC cell line. The preparation and development of these nanoparticles has established a basis for further studies involving cellular toxicity and in vivo anti-tumor action of AF loaded, EGFR-targeted nanoparticles.Citation Format: Ashley M. Brinkman, Guojun Chen, Nathan Sherer, Shaoqin Gong, Wei Xu. Targeting epidermal growth factor receptor positive breast cancer using nanoparticles loaded with the anti-cancer drug aminoflavone. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 5379. doi:10.1158/1538-7445.AM2014-5379" @default.
• W2073075774 created "2016-06-24" @default.
• W2073075774 creator A5000975643 @default.
• W2073075774 creator A5012162881 @default.
• W2073075774 creator A5014879534 @default.
• W2073075774 creator A5039460222 @default.
• W2073075774 creator A5066713162 @default.
• W2073075774 date "2014-09-30" @default.
• W2073075774 modified "2023-09-27" @default.
• W2073075774 title "Abstract 5379: Targeting epidermal growth factor receptor positive breast cancer using nanoparticles loaded with the anti-cancer drug aminoflavone" @default.
• W2073075774 doi "https://doi.org/10.1158/1538-7445.am2014-5379" @default.
• W2073075774 hasPublicationYear "2014" @default.
• W2073075774 type Work @default.
• W2073075774 sameAs 2073075774 @default.
• W2073075774 citedByCount "0" @default.
• W2073075774 crossrefType "proceedings-article" @default.
• W2073075774 hasAuthorship W2073075774A5000975643 @default.
• W2073075774 hasAuthorship W2073075774A5012162881 @default.
• W2073075774 hasAuthorship W2073075774A5014879534 @default.
• W2073075774 hasAuthorship W2073075774A5039460222 @default.
• W2073075774 hasAuthorship W2073075774A5066713162 @default.
• W2073075774 hasConcept C11268172 @default.
• W2073075774 hasConcept C121608353 @default.
• W2073075774 hasConcept C126322002 @default.
• W2073075774 hasConcept C147789679 @default.
• W2073075774 hasConcept C150903083 @default.
• W2073075774 hasConcept C178790620 @default.
• W2073075774 hasConcept C184651966 @default.
• W2073075774 hasConcept C185592680 @default.
• W2073075774 hasConcept C207001950 @default.
• W2073075774 hasConcept C2779438470 @default.
• W2073075774 hasConcept C2779820397 @default.
• W2073075774 hasConcept C2780110267 @default.
• W2073075774 hasConcept C502942594 @default.
• W2073075774 hasConcept C530470458 @default.
• W2073075774 hasConcept C71924100 @default.
• W2073075774 hasConcept C86803240 @default.
• W2073075774 hasConceptScore W2073075774C11268172 @default.
• W2073075774 hasConceptScore W2073075774C121608353 @default.
• W2073075774 hasConceptScore W2073075774C126322002 @default.
• W2073075774 hasConceptScore W2073075774C147789679 @default.
• W2073075774 hasConceptScore W2073075774C150903083 @default.
• W2073075774 hasConceptScore W2073075774C178790620 @default.
• W2073075774 hasConceptScore W2073075774C184651966 @default.
• W2073075774 hasConceptScore W2073075774C185592680 @default.
• W2073075774 hasConceptScore W2073075774C207001950 @default.
• W2073075774 hasConceptScore W2073075774C2779438470 @default.
• W2073075774 hasConceptScore W2073075774C2779820397 @default.
• W2073075774 hasConceptScore W2073075774C2780110267 @default.
• W2073075774 hasConceptScore W2073075774C502942594 @default.
• W2073075774 hasConceptScore W2073075774C530470458 @default.
• W2073075774 hasConceptScore W2073075774C71924100 @default.
• W2073075774 hasConceptScore W2073075774C86803240 @default.
• W2073075774 hasLocation W20730757741 @default.
• W2073075774 hasOpenAccess W2073075774 @default.
• W2073075774 hasPrimaryLocation W20730757741 @default.
• W2073075774 hasRelatedWork W1512612793 @default.
• W2073075774 hasRelatedWork W1968035235 @default.
• W2073075774 hasRelatedWork W2006394837 @default.
• W2073075774 hasRelatedWork W2394497138 @default.
• W2073075774 hasRelatedWork W2397297897 @default.
• W2073075774 hasRelatedWork W2740026810 @default.
• W2073075774 hasRelatedWork W2792754461 @default.
• W2073075774 hasRelatedWork W2797119761 @default.
• W2073075774 hasRelatedWork W2899819879 @default.
• W2073075774 hasRelatedWork W2911737890 @default.
• W2073075774 hasRelatedWork W2944086149 @default.
• W2073075774 hasRelatedWork W2944711182 @default.
• W2073075774 hasRelatedWork W2955010346 @default.
• W2073075774 hasRelatedWork W2975976475 @default.
• W2073075774 hasRelatedWork W3000498605 @default.
• W2073075774 hasRelatedWork W3023819306 @default.
• W2073075774 hasRelatedWork W3025465773 @default.
• W2073075774 hasRelatedWork W3036704114 @default.
• W2073075774 hasRelatedWork W3125566367 @default.
• W2073075774 hasRelatedWork W3165271975 @default.
• W2073075774 isParatext "false" @default.
• W2073075774 isRetracted "false" @default.
• W2073075774 magId "2073075774" @default.
• W2073075774 workType "article" @default.